Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 7 of 7 clinical reviews.
Tirzepatide (Zepbound) changes body composition on DEXA scans. Learn how much fat vs. Lean mass is lost, when to schedule scans, and how to protect muscle during treatment.
Read clinical reviewClinical evidence on how Zepbound (tirzepatide) affects estimated glomerular filtration rate (eGFR), including trial data, magnitude of change, monitoring timelines, and what the numbers mean for kidney health.
Read clinical reviewZepbound (tirzepatide) significantly lowers fasting insulin levels through dual GIP/GLP-1 receptor activity. Learn the magnitude, timeline, mechanism, and monitoring strategy backed by SURMOUNT trial data.
Read clinical reviewTirzepatide (Zepbound) lowers fasting triglycerides by 20 to 30% in clinical trials. Learn the mechanism, timeline, expected magnitude, and monitoring schedule.
Read clinical reviewZepbound (tirzepatide) lowers HbA1c by 0.3 to 2.4 percentage points depending on baseline glucose status. Review the SURMOUNT trial data, mechanism, monitoring schedule, and what to expect.
Read clinical reviewTirzepatide (Zepbound) significantly reduces visceral adipose tissue. Learn the clinical data on VAT loss magnitude, timeline, mechanisms, and monitoring from SURMOUNT trials.
Read clinical reviewTirzepatide (Zepbound) changes kidney function markers, liver enzymes, glucose, and electrolytes on a CMP. Here is what RCT data, FDA labeling, and post-market reports show about direction, magnitude, timing, and monitoring intervals.
Read clinical review